Loading...

You're on the old version of Simply Wall St. We will no longer be supporting this site, so we recommend you switch to our brand new platform.

GMP Capital

TSX:GMP
Snowflake Description

Excellent balance sheet not a dividend payer.

The Snowflake is generated from 30 checks in 5 different areas, read more below.
GMP
TSX
CA$101M
Market Cap
  1. Home
  2. CA
  3. Diversified Financials
Company description

GMP Capital Inc., an independent diversified financial services company, provides various financial products and services to corporate clients, institutional investors, and high-net-worth individuals in Canada, the United States, and internationally. The last earnings update was 30 days ago. More info.


Add to Portfolio Compare Print
  • GMP Capital has significant price volatility in the past 3 months.
GMP Share Price and Events
7 Day Returns
15.3%
TSX:GMP
2%
CA Capital Markets
6.4%
CA Market
1 Year Returns
-37.9%
TSX:GMP
-19.2%
CA Capital Markets
-25.5%
CA Market
GMP Shareholder Return
  7 Day 30 Day 90 Day 1 Year 3 Year 5 Year
GMP Capital (GMP) 15.3% -17.6% -27.7% -37.9% -62.6% -76%
CA Capital Markets 2% -24% -26.2% -19.2% -20% -21.3%
CA Market 6.4% -22.6% -26.8% -25.5% -23.5% -17.4%
1 Year Return vs Industry and Market
  • GMP underperformed the Capital Markets industry which returned -19.2% over the past year.
  • GMP underperformed the Market in Canada which returned -25.5% over the past year.
Price Volatility
GMP
Industry
5yr Volatility vs Market

Value

 Is GMP Capital undervalued based on future cash flows and its price relative to the stock market?

Value is all about what a company is worth versus what price it is available for. If you went into a grocery store and all the bananas were on sale at half price, they could be considered undervalued.
INTRINSIC VALUE BASED ON FUTURE CASH FLOWS
  • It is not possible to calculate the future cash flow value for GMP Capital. This is due to cash flow or dividend data being unavailable. The share price is CA$1.36.
PRICE RELATIVE TO MARKET
We can also value a company based on what the stock market is willing to pay for it. This is similar to the price of fruit (e.g. Mangoes or Avocados) increasing when they are out of season, or how much your home is worth.

The amount the stock market is willing to pay for GMP Capital's earnings, growth and assets is considered below, and whether this is a fair price.
Price based on past earnings
Are GMP Capital's earnings available for a low price, and how does this compare to other companies in the same industry?
Raw Data
TSX:GMP PE (Price to Earnings) Ratio Data Sources
Data Point Source Value
Earnings Per Share * Company Filings (2019-12-31) in CAD CA$-0.26
TSX:GMP Share Price ** TSX (2020-03-27) in CAD CA$1.36
Canada Capital Markets Industry PE Ratio Median Figure of 16 Publicly-Listed Capital Markets Companies 7.37x
Canada Market PE Ratio Median Figure of 500 Publicly-Listed Companies 10.58x

* Trailing twelve months (TTM) annual GAAP earnings per share excluding extraordinary items.

** Primary Listing of GMP Capital.

TSX:GMP PE (Price to Earnings) Ratio Calculation
Calculation Outcome
PE Ratio

= TSX:GMP Share Price ÷ EPS (both in CAD)

= 1.36 ÷ -0.26

-5.28x

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • GMP Capital is loss making, we can't compare its value to the CA Capital Markets industry average.
  • GMP Capital is loss making, we can't compare the value of its earnings to the Canada market.
Price based on expected Growth
Does GMP Capital's expected growth come at a high price?
Raw Data
TSX:GMP PEG (Price to Earnings to Growth) Ratio Data Sources
Data Point Source Value
PE Ratio See PE Ratio Section -5.28x
Net Income Annual Growth Rate See Future Growth Section.
Line of Best Fit* through Consensus Estimate Earnings of 0 Analysts
Not available
North America Capital Markets Industry PEG Ratio Median Figure of 39 Publicly-Listed Capital Markets Companies 1.81x
Canada Market PEG Ratio Median Figure of 235 Publicly-Listed Companies 0.71x

*Line of best fit is calculated by linear regression .

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Unable to calculate PEG ratio for GMP Capital, we can't assess if its growth is good value.
Price based on value of assets
What value do investors place on GMP Capital's assets?
Raw Data
TSX:GMP PB (Price to Book) Ratio Data Sources
Data Point Source Value
Book Value per Share Company Filings (2019-12-31) in CAD CA$1.22
TSX:GMP Share Price * TSX (2020-03-27) in CAD CA$1.36
Canada Capital Markets Industry PB Ratio Median Figure of 157 Publicly-Listed Capital Markets Companies 0.82x
Canada Market PB Ratio Median Figure of 2,349 Publicly-Listed Companies 0.99x
TSX:GMP PB (Price to Book) Ratio Calculation
Calculation Outcome
PB Ratio

= TSX:GMP Share Price ÷ Book Value per Share (both in CAD)

= 1.36 ÷ 1.22

1.11x

* Primary Listing of GMP Capital.

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • GMP Capital is overvalued based on assets compared to the CA Capital Markets industry average.
X
Value checks
We assess GMP Capital's value by looking at:
  1. Is the discounted cash flow value less than 20%, or 40% of the share price? (2 checks) ( Click here or on bar chart for details of DCF calculation. )
  2. Is the PE ratio less than the market average, and/ or less than the Capital Markets industry average (and greater than 0)? (2 checks)
  3. Is the PEG ratio within a reasonable range (0 to 1)? (1 check)
  4. Is the PB ratio less than the Capital Markets industry average (and greater than 0)? (1 check)
  5. GMP Capital has a total score of 0/6, see the detailed checks below.

    Note: We use GAAP Earnings per Share in all our calculations including PE and PEG Ratio.

    Full details on the Value part of the Simply Wall St company analysis model.

Future Performance

 How is GMP Capital expected to perform in the next 1 to 3 years based on estimates from 0 analysts?

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as GMP Capital has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by Simply Wall St do have past financial data. You can see them here.

Show me the analysis anyway

The future performance of a company is measured in the same way as past performance, by looking at estimated growth and how much profit it is expected to make.

Future estimates come from professional analysts. Just like forecasting the weather, they don’t always get it right!
Annual Growth Rate
5.8%
Expected Capital Markets industry annual growth in earnings.
Earnings growth vs Low Risk Savings
Is GMP Capital expected to grow at an attractive rate?
  • Unable to compare GMP Capital's earnings growth to the low risk savings rate as no estimate data is available.
Growth vs Market Checks
  • Unable to compare GMP Capital's earnings growth to the Canada market average as no estimate data is available.
  • Unable to compare GMP Capital's revenue growth to the Canada market average as no estimate data is available.
Annual Growth Rates Comparison
Raw Data
TSX:GMP Future Growth Rates Data Sources
Data Point Source Value (per year)
North America Capital Markets Industry Earnings Growth Rate Market Cap Weighted Average 5.8%
North America Capital Markets Industry Revenue Growth Rate Market Cap Weighted Average 2.6%
Canada Market Earnings Growth Rate Market Cap Weighted Average 7.6%
Canada Market Revenue Growth Rate Market Cap Weighted Average 3.9%

*Line of best fit is calculated by linear regression .

Industry and Market average data is calculated daily.

Learn more about our growth rate calculations in Simply Wall St’s analysis model.

Analysts growth expectations
Raw Data
TSX:GMP Analysts Growth Expectations Data Sources
Data Point Source Value
Past Financials Company Filings (2 months ago) See Below
Future Estimates Average of up to 0 Analyst Estimates (S&P Global) See Below
All numbers in CAD Millions and using Trailing twelve months (TTM) annual period rather than quarterly.
TSX:GMP Past Financials Data
Date (Data in CAD Millions) Revenue Cash Flow Net Income *
2019-12-31 20 3 -18
2019-09-30 164 -33 12
2019-06-30 164 50 13
2019-03-31 155 -32 -17
2018-12-31 23 -88 -7
2018-09-30 38 3 -9
2018-06-30 67 -57 -5
2018-03-31 142 19 -47
2017-12-31 145 109 -48
2017-09-30 182 93 -54
2017-06-30 192 0 -63
2017-03-31 192 101 -9

*GAAP earnings excluding extraordinary items.

Super high growth metrics
High Growth Checks
  • Unable to determine if GMP Capital is high growth as no earnings estimate data is available.
  • Unable to determine if GMP Capital is high growth as no revenue estimate data is available.
Past and Future Earnings per Share
The accuracy of the analysts who estimate the future performance data can be gauged below. We look back 3 years and see if they were any good at predicting what actually occurred. We also show the highest and lowest estimates looking forward to see if there is a wide range.
Raw Data
TSX:GMP Past and Future Earnings per Share
Data Point Source Value
Past Financials Company Filings (2 months ago) See Below
Future Estimates Average of up to 0 Analyst Estimates (S&P Global) See Below

All data from GMP Capital Company Filings, last reported 2 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

TSX:GMP Past Financials Data
Date (Data in CAD Millions) EPS *
2019-12-31 -0.26
2019-09-30 0.18
2019-06-30 0.19
2019-03-31 -0.26
2018-12-31 -0.10
2018-09-30 -0.13
2018-06-30 -0.07
2018-03-31 -0.68
2017-12-31 -0.70
2017-09-30 -0.78
2017-06-30 -0.91
2017-03-31 -0.13

*GAAP earnings excluding extraordinary items.

Performance in 3 years
In the same way as past performance we look at the future estimated return (profit) compared to the available funds. We do this looking forward 3 years.
  • Unable to establish if GMP Capital will efficiently use shareholders’ funds in the future without estimates of Return on Equity.

Next steps:

  1. Examine GMP Capital's financial health to determine how well-positioned it is against times of financial stress by looking at its level of debt over time and how much cash it has left.
  2. GMP Capital's future outlook can be gauged by looking at industry trends and market size, and determining how well-positioned the company is compared to its competitors. Take a look at other high-growth Diversified Financials companies here
  3. GMP Capital's competitive advantages and company strategy can generally be found in its financial reports archived here.
  4. Use fundamentals to screen for another stock to analyse from our database of over 75,000 companies worldwide
X
Future performance checks
We assess GMP Capital's future performance by looking at:
  1. Is the annual earnings growth rate expected to beat the low risk savings rate, plus a premium to keep pace with inflation?
  2. Is the annual earnings growth rate expected to beat the average growth rate in earnings of the North America market? (1 check)
  3. Is the annual revenue growth rate expected to beat the average growth rate in revenue of the North America market? (1 check)
  4. Is the annual earnings growth rate expected to be above 20%? (1 check)
  5. Is the annual revenue growth rate expected to be above 20%? (1 check)
  6. Is the Return on Equity in 3 years expected to be over 20%? (1 check)
Some of the above checks will fail if the company is expected to be loss making in the relevant year.
GMP Capital has a total score of 0/6, see the detailed checks below.

Note 1: We use GAAP Net Income Excluding Exceptional Items for our Earnings in all our calculations.

Full details on the Future part of the Simply Wall St company analysis model.

Past Performance

  How has GMP Capital performed over the past 5 years?

The past performance of a company can be measured by how much growth it has experienced and how much profit it makes relative to the funds and assets it has available.
Past earnings growth
Below we compare GMP Capital's growth in the last year to its industry (Capital Markets).
Past Earnings growth analysis
We also check if the company has grown in the past 5 years, and whether it has maintained that growth in the year.
  • GMP Capital does not make a profit even though their year on year earnings growth rate was positive over the past 5 years.
  • Unable to compare GMP Capital's 1-year earnings growth to the 5-year average as it is not currently profitable.
  • Unable to compare GMP Capital's 1-year growth to the CA Capital Markets industry average as it is not currently profitable.
Earnings and Revenue History
GMP Capital's revenue and profit over the past 5 years is shown below, any years where they have experienced a loss will show up in red.
Raw Data

All data from GMP Capital Company Filings, last reported 2 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

TSX:GMP Past Revenue, Cash Flow and Net Income Data
Date (Data in CAD Millions) Revenue Net Income * G+A Expenses R&D Expenses
2019-12-31 20.26 -18.11 14.24
2019-09-30 163.53 12.23 92.86
2019-06-30 163.75 13.20 97.56
2019-03-31 154.81 -17.47 95.34
2018-12-31 22.62 -6.67 12.76
2018-09-30 38.25 -8.70 30.78
2018-06-30 66.67 -4.97 47.22
2018-03-31 142.29 -46.53 92.53
2017-12-31 144.65 -48.39 93.18
2017-09-30 182.03 -54.41 123.06
2017-06-30 192.44 -62.69 122.49
2017-03-31 191.84 -8.62 119.35
2016-12-31 189.56 -16.21 123.78
2016-09-30 156.88 -35.47 115.48
2016-06-30 166.92 -35.70 134.49
2016-03-31 204.10 -29.94 157.34
2015-12-31 211.63 -34.39 167.98
2015-09-30 232.92 -25.68 176.66
2015-06-30 247.07 -9.52 176.51
2015-03-31 248.73 -3.18 174.37
2014-12-31 259.37 8.57 170.44
2014-09-30 277.19 21.09 170.33
2014-06-30 252.01 16.57 154.46
2014-03-31 231.98 2.16 146.19
2013-12-31 206.27 -1.49 139.99
2013-09-30 219.26 -0.12 151.79
2013-06-30 234.86 -1.34 168.05
2013-03-31 237.15 -1.94 173.28

*GAAP earnings excluding extraordinary items.

Performance last year
We want to ensure a company is making the most of what it has available. This is done by comparing the return (profit) to a company's available funds, assets and capital.
  • It is difficult to establish if GMP Capital has efficiently used shareholders’ funds last year (Return on Equity greater than 20%) as it is loss-making.
  • It is difficult to establish if GMP Capital has efficiently used its assets last year compared to the CA Capital Markets industry average (Return on Assets) as it is loss-making.
  • It is difficult to establish if GMP Capital improved its use of capital last year versus 3 years ago (Return on Capital Employed) as it is currently loss-making.
X
Past performance checks
We assess GMP Capital's performance over the past 5 years by checking for:
  1. Has earnings increased in past 5 years? (1 check)
  2. Has the earnings growth in the last year exceeded that of the Capital Markets industry? (1 check)
  3. Is the recent earnings growth over the last year higher than the average annual growth over the past 5 years? (1 check)
  4. Is the Return on Equity (ROE) higher than 20%? (1 check)
  5. Is the Return on Assets (ROA) above industry average? (1 check)
  6. Has the Return on Capital Employed (ROCE) increased from 3 years ago? (1 check)
The above checks will fail if the company has reported a loss in the most recent earnings report. Some checks require at least 3 or 5 years worth of data.
GMP Capital has a total score of 0/6, see the detailed checks below.

Note: We use GAAP Net Income excluding extraordinary items in all our calculations.

Full details on the Past part of the Simply Wall St company analysis model.

Health

 How is GMP Capital's financial health and their level of debt?

A company's financial position is much like your own financial position, it includes everything you own (assets) and owe (liabilities).

The boxes below represent the relative size of what makes up GMP Capital's finances.

The net worth of a company is the difference between its assets and liabilities.
Net Worth
  • GMP Capital is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
  • GMP Capital's cash and other short term assets cover its long term commitments.
Balance sheet
This treemap shows a more detailed breakdown of GMP Capital's finances. If any of them are yellow this indicates they may be out of proportion and red means they relate to one of the checks below.
Assets
Liabilities and shares
The 'shares' portion represents any funds contributed by the owners (shareholders) and any profits.
  • Low level of unsold assets.
  • Debt is covered by short term assets, assets are 81.6x debt.
Historical Debt
Nearly all companies have debt. Debt in itself isn’t bad, however if the debt is too high, or the company can’t afford to pay the interest on its debts this may have impacts in the future.

The graphic below shows equity (available funds) and debt, we ideally want to see the red area (debt) decreasing.

If there is any debt we look at the companies capability to repay it, and whether the level has increased over the past 5 years.
Raw Data

All data from GMP Capital Company Filings, last reported 2 months ago.

TSX:GMP Past Debt and Equity Data
Date (Data in CAD Millions) Total Equity Total Debt Cash & Short Term Investments
2019-12-31 202.86 15.60 582.04
2019-09-30 231.23 15.34 470.70
2019-06-30 257.79 29.09 586.20
2019-03-31 263.27 28.90 635.14
2018-12-31 290.03 28.70 626.35
2018-09-30 295.88 28.50 793.99
2018-06-30 293.65 28.30 590.21
2018-03-31 293.37 28.11 678.54
2017-12-31 293.43 39.82 737.00
2017-09-30 284.52 39.65 639.34
2017-06-30 289.09 39.32 719.54
2017-03-31 342.06 39.00 691.94
2016-12-31 336.11 39.61 617.07
2016-09-30 334.37 38.72 534.31
2016-06-30 325.63 0.00 786.35
2016-03-31 325.72 0.00 577.60
2015-12-31 337.13 4.02 618.37
2015-09-30 350.18 3.44 612.54
2015-06-30 363.30 2.88 558.43
2015-03-31 362.96 3.71 754.97
2014-12-31 370.29 0.41 616.73
2014-09-30 389.03 0.00 576.19
2014-06-30 388.11 0.00 628.17
2014-03-31 389.25 0.00 772.93
2013-12-31 387.13 0.00 569.38
2013-09-30 351.78 0.00 397.49
2013-06-30 356.10 0.00 515.49
2013-03-31 366.94 0.00 436.20
  • GMP Capital's level of debt (7.7%) compared to net worth is satisfactory (less than 40%).
  • The level of debt compared to net worth has increased over the past 5 years (0.1% vs 7.7% today).
CASH RUNWAY ANALYSIS

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

  • Whilst loss making GMP Capital has sufficient cash runway for more than 3 years if it maintains the current positive free cash flow level.
  • Whilst loss making GMP Capital has sufficient cash runway for more than 3 years, due to free cash flow being positive and growing by 34% per year.
X
Financial health checks
We assess GMP Capital's financial health by checking for:
  1. Are short term assets greater than short term liabilities? (1 check)
  2. Are short term assets greater than long term liabilities? (1 check)
  3. Has the debt to equity ratio increased in the past 5 years? (1 check)
  4. Is the debt to equity ratio over 40%? (1 check)
  5. Is the debt covered by operating cash flow? (1 check)
  6. Are earnings greater than 5x the interest on debt (if company pays interest at all)? (1 check)
  7. GMP Capital has a total score of 5/6, see the detailed checks below.
For companies that are loss making and have been so on average in the past we replace the last 2 checks with:
  1. Does cash and short term investments cover stable operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)
  2. Does cash and short term investments cover growing operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)


Full details on the Health part of the Simply Wall St company analysis model.

Dividends

 What is GMP Capital's current dividend yield, its reliability and sustainability?

Dividends are regular cash payments to you from the company, similar to a bank paying you interest on a savings account.
Annual Dividend Income
Dividend payments
7.35%
Current annual income from GMP Capital dividends.
If you bought CA$2,000 of GMP Capital shares you are expected to receive CA$147 in your first year as a dividend.
Dividend Amount
Here we look how much dividend is being paid, if any. Is it above what you can get in a savings account? It is up there with the best dividend paying companies?
  • GMP Capital's pays a higher dividend yield than the bottom 25% of dividend payers in Canada (2.73%).
  • GMP Capital's dividend is below the markets top 25% of dividend payers in Canada (8.76%).
Annualized Historical and Future Dividends
It is important to see if the dividend for a company is stable, and not wildly increasing/decreasing each year. This graph shows you the historical rate to count toward your assessment of the stock.

We also check to see if the dividend has increased in the past 10 years.
Raw Data
TSX:GMP Annualized Past and Future Dividends
Data Point Source Value
Past Annualized Dividend Yield S&P Global Market Data See Below
Past Dividends per Share Company Filings/ Annualized Dividend Payments See Below
Future Dividends per Share Estimates Average of up to 0 Analyst Estimates (S&P Global) See Below
Canada Capital Markets Industry Average Dividend Yield Market Cap Weighted Average of 9 Stocks 6.2%
Canada Market Average Dividend Yield Market Cap Weighted Average of 326 Stocks 4.9%
Canada Minimum Threshold Dividend Yield 10th Percentile 1.3%
Canada Bottom 25% Dividend Yield 25th Percentile 2.7%
Canada Top 25% Dividend Yield 75th Percentile 8.8%

Industry and Market average data is calculated daily.

Note all dividend per share amounts are annualized and not quarterly or other period.

TSX:GMP Past Annualized Dividends Data
Date (Data in CA$) Dividend per share (annual) Avg. Yield (%)
2020-02-28 0.100 7.120
2019-11-08 0.100 5.083
2019-08-09 0.100 4.089
2019-05-02 0.100 4.397
2019-03-01 0.100 4.561
2018-11-09 0.100 4.721
2017-08-04 0.000 0.000
2017-04-27 0.000 0.000
2017-03-03 0.000 0.000
2016-11-02 0.000 0.000
2016-08-05 0.000 0.000
2016-04-28 0.000 0.000
2016-04-15 0.000 0.000
2016-03-11 0.000 0.000
2015-11-06 0.200 4.827
2015-08-07 0.200 4.706
2015-04-30 0.200 3.986
2015-03-06 0.200 3.676
2014-11-07 0.200 3.511
2014-08-08 0.200 2.743
2014-05-01 0.200 2.408
2014-03-04 0.200 2.587
2013-11-08 0.200 2.925
2013-08-09 0.200 3.202
2013-05-03 0.200 3.245
2013-04-11 0.200 3.624
2013-03-01 0.200 3.152
2012-11-09 0.200 3.342
2012-08-03 0.200 3.695
2012-05-04 0.200 3.749
2012-03-14 0.400 5.854
2011-11-04 0.400 5.379
2011-08-05 0.400 5.185
2011-05-06 0.400 3.088
2011-03-02 0.320 2.081
2010-11-05 0.240 1.801
2010-08-06 0.240 2.273
2010-05-07 0.200 2.014
2010-03-02 0.200 1.484
2009-11-05 0.200 1.617
2009-06-18 0.200 1.654

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Dividends per share have been volatile in the past 10 years (annual drop of over 20%).
  • Dividends per share have fallen over the past 10 years.
Current Payout to shareholders
What portion of GMP Capital's earnings are paid to the shareholders as a dividend.
  • The company is paying a dividend however it is incurring a loss.
Future Payout to shareholders
  • Insufficient estimate data to determine if a dividend will be paid in 3 years and that it will be sustainable.
X
Income/ dividend checks
We assess GMP Capital's dividend by checking for:
  1. Firstly is the company paying a notable dividend (greater than 1.3%) - if not then the rest of the checks are ignored.
  2. Is current dividend yield above the bottom 25% of dividend payers? (1 check)
  3. Is current dividend yield above the top 25% of dividend payers? (1 check)
  4. Have they paid a dividend for 10 years, and during this period has the dividend been volatile (drop of more than 25%)? (1 check)
  5. If they have paid a dividend for 10 years has it increased in this time? (1 check)
  6. How sustainable is the dividend, can GMP Capital afford to pay it from its earnings today and in 3 years (Payout ratio less than 90%)? (2 checks)
  7. GMP Capital has a total score of 1/6, see the detailed checks below.


Full details on the Dividends part of the Simply Wall St company analysis model.

Management

 What is the CEO of GMP Capital's salary, the management and board of directors tenure and is there insider trading?

Management is one of the most important areas of a company. We look at unreasonable CEO compensation, how long the team and board of directors have been around for and insider trading.
CEO
Kish Kapoor
COMPENSATION CA$76,377
AGE 62
TENURE AS CEO 0.6 years
CEO Bio

Mr. Kishore K. Kapoor, also known as Kish, CPA, CA has been Interim President and Chief Executive Officer at GMP Capital Inc. since August 09, 2019 and has been its Director since August 09, 2019. He was an Independent Director of GMP Capital Inc. from June 18, 2018 to August 09, 2019. Mr. Kapoor is a Director of Morneau Shepell Inc., since August 15, 2018. He has been Independent Director of Equitable Group Inc from May 2011 and Equitable Bank since November 2016. Mr. Kapoor served as the President of Wellington West Holdings Inc. until July 2011. Mr. Kapoor has extensive experience in the Canadian financial services industry. From November 2003 to June 2005, he served as an Executive Vice-President of Corporate Development at Loring Ward International Ltd and Loring Ward International Inc., which was formed to hold the U.S. operations of Assante Corporation. As one of the founders of Assante, Mr. Kapoor served as Executive Vice President of Corporate Development from March 1994 to November 2003, where he was instrumental in the development and execution of their corporate strategy. He played an important role in taking Assante public, which led to the sale of their Canadian operations, in 2003, to CI Financial. Mr. Kapoor was a Tax Partner with KPMG LLP. During his 14 years with KPMG LLP, he specialized in offering clients advice on tax, corporate finance, mergers and acquisitions and development of corporate strategy in a wide range of industries, including those in the biotechnology sector. He has been a Director of Richardson Financial Group Limited since July 30, 2014. Mr. Kapoor serves as Director at Richardson GMP Limited. Mr. Kapoor served as an Independent Director of Manitoba Telecom Services, Inc. since May 2, 2006 until March 2017 and Medicure Inc. since July 28, 2006. He serves as a Director of Allstream Inc. (formerly MTS Allstream, Inc.). He holds a Bachelor of Science degree from University of Manitoba and is a Chartered Accountant.

CEO Compensation
  • Insufficient data for Kish to compare compensation growth.
  • Kish's remuneration is lower than average for companies of similar size in Canada.
Management Team Tenure

Average tenure of the GMP Capital management team in years:

3.8
Average Tenure
  • The tenure for the GMP Capital management team is about average.
Management Team

Kish Kapoor

TITLE
Interim President
COMPENSATION
CA$76K
AGE
62
TENURE
0.6 yrs

Gene McBurney

TITLE
Director
COMPENSATION
CA$2M
AGE
70

Debbie Starkman

TITLE
CFO & Corporate Secretary
COMPENSATION
CA$900K
TENURE
7.5 yrs

Chris Bond

TITLE
Vice Chairman & Head of Institutional Trading of GMP Securities
COMPENSATION
CA$1M

Rob Weir

TITLE
Vice Chairman & Head of Institutional Equity Sales of GMP Securities
COMPENSATION
CA$2M
TENURE
4.2 yrs

Rocco Colella

TITLE
Managing Director of Investor Relations

Chris Hill

TITLE
Chief Compliance Officer

Krista Coburn

TITLE
General Counsel & Corporate Secretary

John Chambers

TITLE
Vice Chairman & President of GMP FirstEnergy
TENURE
3.4 yrs

Daryl Rudichuk

TITLE
Managing Director
Board of Directors Tenure

Average tenure and age of the GMP Capital board of directors in years:

5.7
Average Tenure
64
Average Age
  • The tenure for the GMP Capital board of directors is about average.
Board of Directors

Don Wright

TITLE
Independent Chairman of the Board
COMPENSATION
CA$244K
AGE
71

Kish Kapoor

TITLE
Interim President
COMPENSATION
CA$76K
AGE
62
TENURE
1.8 yrs

Gene McBurney

TITLE
Director
COMPENSATION
CA$2M
AGE
70
TENURE
11.8 yrs

Fiona Macdonald

TITLE
Independent Director
COMPENSATION
CA$163K
AGE
64
TENURE
6.6 yrs

David Ferguson

TITLE
Independent Director
COMPENSATION
CA$189K
AGE
67
TENURE
5.6 yrs

Julie A. Lassonde

TITLE
Independent Director
COMPENSATION
CA$52K
AGE
47
TENURE
1.5 yrs

Dave Brown

TITLE
Independent Director
COMPENSATION
CA$125K
AGE
59
TENURE
5.8 yrs
Who owns this company?
Recent Insider Trading
  • No 3 month open market individual insider trading information.
Recent Insider Transactions
Announced Type Name Entity Role Start End Shares Max Price (CA$) Value (CA$)
X
Management checks
We assess GMP Capital's management by checking for:
  1. Is the CEO's compensation unreasonable compared to market cap? (1 check)
  2. Has the CEO's compensation increased more than 20% whilst the EPS is down more then 20%? (1 check)
  3. Is the average tenure of the management team less than 2 years? (1 check)
  4. Is the average tenure of the board of directors team less than 3 years? (1 check)
  5. GMP Capital has a total score of 0/6, this is not included on the snowflake, see the detailed checks below.


Note: We use the top 6 management executives and board members in our calculations.

Note 2: Insider trading include any internal stakeholders and these transactions .

Full details on the Management part of the Simply Wall St company analysis model.

News

Simply Wall St News

Consider This Before Buying GMP Capital Inc. (TSE:GMP) For The 3.8% Dividend

(TSE:GMP) from a dividend investor's perspective. Owning a strong business and reinvesting the dividends is widely seen as an attractive way of growing your wealth. If you are hoping to live on the income from dividends, it's important to be a lot more stringent with your investments than the average punter. A high yield and a long history of paying dividends is an appealing combination for GMP Capital. We'd guess that plenty of investors have purchased it for the income. The company also bought back stock during the year, equivalent to approximately 1.6% of the company's market capitalisation at the time. That said, the recent jump in the share price will make GMP Capital's dividend yield look smaller, even though the company prospects could be improving. Before you buy any stock for its dividend however, you should always remember Warren Buffett's two rules: 1) Don't lose money, and 2) Remember rule #1. … GMP Capital has been paying dividends for a long time, but for the purpose of this analysis, we only examine the past 10 years of payments. … We struggle to make a case for buying GMP Capital for its dividend, given that payments have shrunk over the past ten years.

Simply Wall St -

Some GMP Capital (TSE:GMP) Shareholders Have Copped A Big 67% Share Price Drop

Check out our latest analysis for GMP Capital Given that GMP Capital didn't make a profit in the last twelve months, we'll focus on revenue growth to form a quick view of its business development. … As well as measuring the share price return, investors should also consider the total shareholder return (TSR). … That exceeds its share price return that we previously mentioned.

Simply Wall St -

How Does Investing In GMP Capital Inc. (TSE:GMP) Impact The Volatility Of Your Portfolio?

Beta can be a useful tool to understand how much a stock is influenced by market risk (volatility). … A stock with a beta below one is either less volatile than the market, or more volatile but not corellated with the overall market. … In comparison a stock with a beta of over one tends to be move in a similar direction to the market in the long term, but with greater changes in price.

Simply Wall St -

Easy Come, Easy Go: How GMP Capital (TSE:GMP) Shareholders Got Unlucky And Saw 73% Of Their Cash Evaporate

(TSE:GMP) share price managed to fall 73% over five long years. … Unfortunately the share price momentum is still quite negative, with prices down 8.3% in thirty days. … The most recent dividend was actually lower than it was in the past, so that may have sent the share price lower.

Simply Wall St -

What Type Of Shareholder Owns GMP Capital Inc.'s (TSE:GMP)?

Taking a look at our data on the ownership groups (below), it's seems that. … institutional investors have bought into the company … We can zoom in on the different ownership groups, to learn more about GMP

Simply Wall St -

What Did GMP Capital Inc.'s (TSE:GMP) CEO Take Home Last Year?

This analysis aims first to contrast CEO compensation with other companies that have similar market capitalization. … Check out our latest analysis for GMP Capital … How Does Harris Fricker's Compensation Compare With Similar Sized Companies?

Simply Wall St -

What You Must Know About GMP Capital Inc.'s (TSE:GMP) Beta Value

Beta is a widely used metric to measure a stock's exposure to market risk (volatility). … A stock with a beta below one is either less volatile than the market, or more volatile but not corellated with the overall market. … In comparison a stock with a beta of over one tends to be move in a similar direction to the market in the long term, but with greater changes in price.

Simply Wall St -

Is GMP Capital Inc's (TSE:GMP) CEO Pay Justified?

This analysis aims first to contrast CEO compensation with other companies that have similar market capitalization. … According to our data, GMP Capital Inc has a market capitalization of CA$137m, and pays its CEO total annual compensation worth CA$3m. … It would therefore appear that GMP Capital Inc pays Harris Fricker more than the median CEO remuneration at companies of a similar size, in the same market

Simply Wall St -

GMP Capital Inc (TSE:GMP): How Does It Impact Your Portfolio?

The other type of risk, which cannot be diversified away, is market risk. … Every stock in the market is exposed to this risk, which arises from macroeconomic factors such as economic growth and geo-political tussles just to name a few. … The most widely used metric to quantify a stock's market risk is beta, and the market as a whole represents a beta of one.

Simply Wall St -

Is GMP Capital Inc (TSE:GMP) Excessively Paying Its CEO?

Leading GMP Capital Inc (TSE:GMP) as the CEO, Harris Fricker took the company to a valuation of CA$211.54m. … Understanding how CEOs are incentivised to run and grow their company is an important aspect of investing in a stock. … CEOs leading companies of similar size and profitability

Simply Wall St -

Company Info

Description

GMP Capital Inc., an independent diversified financial services company, provides various financial products and services to corporate clients, institutional investors, and high-net-worth individuals in Canada, the United States, and internationally. It operates in two segments, Capital Markets and Wealth Management. The Capital Markets segment offers investment banking services, including advisory and underwriting services, institutional research and sales, and trading services. The Wealth Management segment provides wealth management and investment services. GMP Capital Inc. was founded in 1995 and is headquartered in Toronto, Canada.

Details
Name: GMP Capital Inc.
GMP
Exchange: TSX
Founded: 1995
CA$100,860,989
74,162,492
Website: http://www.gmpcapital.com
Address: GMP Capital Inc.
145 King Street West,
Suite 300,
Toronto,
Ontario, M5H 1J8,
Canada
Listings
Exchange Symbol Ticker Symbol Security Exchange Country Currency Listed on
TSX GMP Common Stock The Toronto Stock Exchange CA CAD 09. Dec 2003
OTCPK GMPX.F Common Stock Pink Sheets LLC US USD 09. Dec 2003
DB G04 Common Stock Deutsche Boerse AG DE EUR 09. Dec 2003
TSX GMP.PRB PFD-B 5YR REST The Toronto Stock Exchange CA CAD 22. Feb 2011
Number of employees
Current staff
Staff numbers
44
GMP Capital employees.
Industry
Investment Banking and Brokerage
Diversified Financials
Company Analysis and Financial Data Status
Area Date (UTC time)
Company Analysis updated: 2020/03/29 03:39
End of day share price update: 2020/03/27 00:00
Last earnings filing: 2020/02/28
Last earnings reported: 2019/12/31
Last annual earnings reported: 2019/12/31


All dates and times in UTC. All financial data provided by Standard & Poor’s Capital IQ.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.